209 related articles for article (PubMed ID: 21301403)
1. Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
[No Abstract] [Full Text] [Related]
2. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
3. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
4. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
5. [Hormone replacement therapy in menopause].
Breckwoldt M
Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
[No Abstract] [Full Text] [Related]
6. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy. A year in review.
Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
[TBL] [Abstract][Full Text] [Related]
8. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
[No Abstract] [Full Text] [Related]
9. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
Lippert TH; Mueck AO
MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
[No Abstract] [Full Text] [Related]
10. Pfizer ordered to pay $103m over hormone drugs and breast cancer.
Tanne JH
BMJ; 2009 Nov; 339():b5085. PubMed ID: 19946002
[No Abstract] [Full Text] [Related]
11. Women seek alternatives to hormone replacement therapy.
Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
[No Abstract] [Full Text] [Related]
12. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
13. Hormone therapy's unanswered questions.
Harv Womens Health Watch; 2004 Jul; 11(11):1. PubMed ID: 15273055
[No Abstract] [Full Text] [Related]
14. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
von Schoultz B
Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
[No Abstract] [Full Text] [Related]
15. The estrogen and progestin dilemma: new advice, labeling guidelines.
Bren L
FDA Consum; 2003; 37(2):10-1. PubMed ID: 12715763
[No Abstract] [Full Text] [Related]
16. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
Murkes D; Conner P; Leifland K; Tani E; Beliard A; Lundström E; Söderqvist G
Fertil Steril; 2011 Mar; 95(3):1188-91. PubMed ID: 21067727
[TBL] [Abstract][Full Text] [Related]
17. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
18. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
[TBL] [Abstract][Full Text] [Related]
19. Good science or good marketing?
Head K
Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
[No Abstract] [Full Text] [Related]
20. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
